Cargando…
RASSF10 Is a TGFβ-Target That Regulates ASPP2 and E-Cadherin Expression and Acts as Tumor Suppressor That Is Epigenetically Downregulated in Advanced Cancer
The Ras Association Domain Family (RASSF) encodes members of tumor suppressor genes which are frequently inactivated in human cancers. Here, the function and the regulation of RASSF10, that contains a RA (Ras-association) and two coiled domains, was investigated. We utilized mass spectrometry and im...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6966473/ https://www.ncbi.nlm.nih.gov/pubmed/31817988 http://dx.doi.org/10.3390/cancers11121976 |
_version_ | 1783488741136924672 |
---|---|
author | Richter, Antje M. Küster, Miriam M. Woods, Michelle L. Walesch, Sara K. Gökyildirim, Mira Y. Krueger, Marcus Dammann, Reinhard H. |
author_facet | Richter, Antje M. Küster, Miriam M. Woods, Michelle L. Walesch, Sara K. Gökyildirim, Mira Y. Krueger, Marcus Dammann, Reinhard H. |
author_sort | Richter, Antje M. |
collection | PubMed |
description | The Ras Association Domain Family (RASSF) encodes members of tumor suppressor genes which are frequently inactivated in human cancers. Here, the function and the regulation of RASSF10, that contains a RA (Ras-association) and two coiled domains, was investigated. We utilized mass spectrometry and immuno-precipitation to identify interaction partners of RASSF10. Additionally, we analyzed the up- and downstream pathways of RASSF10 that are involved in its tumor suppressive function. We report that RASSF10 binds ASPP1 (Apoptosis-stimulating protein of p53) and ASPP2 through its coiled-coils. Induction of RASSF10 leads to increased protein levels of ASPP2 and acts negatively on cell cycle progression. Interestingly, we found that RASSF10 is a target of the EMT (epithelial mesenchymal transition) driver TGFβ (Transforming growth factor beta) and that negatively associated genes of RASSF10 are significantly over-represented in an EMT gene set collection. We observed a positive correlation of RASSF10 expression and E-cadherin that prevents EMT. Depletion of RASSF10 by CRISPR/Cas9 technology induces the ability of lung cancer cells to proliferate and to invade an extracellular matrix after TGFβ treatment. Additionally, knockdown of RASSF10 or ASPP2 induced constitutive phosphorylation of SMAD2 (Smad family member 2). Moreover, we found that epigenetic reduction of RASSF10 levels correlates with tumor progression and poor survival in human cancers. Our study indicates that RASSF10 acts a TGFβ target gene and negatively regulates cell growth and invasion through ASPP2. This data suggests that epigenetic loss of RASSF10 contributes to tumorigenesis by promoting EMT induced by TGFβ. |
format | Online Article Text |
id | pubmed-6966473 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-69664732020-01-27 RASSF10 Is a TGFβ-Target That Regulates ASPP2 and E-Cadherin Expression and Acts as Tumor Suppressor That Is Epigenetically Downregulated in Advanced Cancer Richter, Antje M. Küster, Miriam M. Woods, Michelle L. Walesch, Sara K. Gökyildirim, Mira Y. Krueger, Marcus Dammann, Reinhard H. Cancers (Basel) Article The Ras Association Domain Family (RASSF) encodes members of tumor suppressor genes which are frequently inactivated in human cancers. Here, the function and the regulation of RASSF10, that contains a RA (Ras-association) and two coiled domains, was investigated. We utilized mass spectrometry and immuno-precipitation to identify interaction partners of RASSF10. Additionally, we analyzed the up- and downstream pathways of RASSF10 that are involved in its tumor suppressive function. We report that RASSF10 binds ASPP1 (Apoptosis-stimulating protein of p53) and ASPP2 through its coiled-coils. Induction of RASSF10 leads to increased protein levels of ASPP2 and acts negatively on cell cycle progression. Interestingly, we found that RASSF10 is a target of the EMT (epithelial mesenchymal transition) driver TGFβ (Transforming growth factor beta) and that negatively associated genes of RASSF10 are significantly over-represented in an EMT gene set collection. We observed a positive correlation of RASSF10 expression and E-cadherin that prevents EMT. Depletion of RASSF10 by CRISPR/Cas9 technology induces the ability of lung cancer cells to proliferate and to invade an extracellular matrix after TGFβ treatment. Additionally, knockdown of RASSF10 or ASPP2 induced constitutive phosphorylation of SMAD2 (Smad family member 2). Moreover, we found that epigenetic reduction of RASSF10 levels correlates with tumor progression and poor survival in human cancers. Our study indicates that RASSF10 acts a TGFβ target gene and negatively regulates cell growth and invasion through ASPP2. This data suggests that epigenetic loss of RASSF10 contributes to tumorigenesis by promoting EMT induced by TGFβ. MDPI 2019-12-08 /pmc/articles/PMC6966473/ /pubmed/31817988 http://dx.doi.org/10.3390/cancers11121976 Text en © 2019 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Richter, Antje M. Küster, Miriam M. Woods, Michelle L. Walesch, Sara K. Gökyildirim, Mira Y. Krueger, Marcus Dammann, Reinhard H. RASSF10 Is a TGFβ-Target That Regulates ASPP2 and E-Cadherin Expression and Acts as Tumor Suppressor That Is Epigenetically Downregulated in Advanced Cancer |
title | RASSF10 Is a TGFβ-Target That Regulates ASPP2 and E-Cadherin Expression and Acts as Tumor Suppressor That Is Epigenetically Downregulated in Advanced Cancer |
title_full | RASSF10 Is a TGFβ-Target That Regulates ASPP2 and E-Cadherin Expression and Acts as Tumor Suppressor That Is Epigenetically Downregulated in Advanced Cancer |
title_fullStr | RASSF10 Is a TGFβ-Target That Regulates ASPP2 and E-Cadherin Expression and Acts as Tumor Suppressor That Is Epigenetically Downregulated in Advanced Cancer |
title_full_unstemmed | RASSF10 Is a TGFβ-Target That Regulates ASPP2 and E-Cadherin Expression and Acts as Tumor Suppressor That Is Epigenetically Downregulated in Advanced Cancer |
title_short | RASSF10 Is a TGFβ-Target That Regulates ASPP2 and E-Cadherin Expression and Acts as Tumor Suppressor That Is Epigenetically Downregulated in Advanced Cancer |
title_sort | rassf10 is a tgfβ-target that regulates aspp2 and e-cadherin expression and acts as tumor suppressor that is epigenetically downregulated in advanced cancer |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6966473/ https://www.ncbi.nlm.nih.gov/pubmed/31817988 http://dx.doi.org/10.3390/cancers11121976 |
work_keys_str_mv | AT richterantjem rassf10isatgfbtargetthatregulatesaspp2andecadherinexpressionandactsastumorsuppressorthatisepigeneticallydownregulatedinadvancedcancer AT kustermiriamm rassf10isatgfbtargetthatregulatesaspp2andecadherinexpressionandactsastumorsuppressorthatisepigeneticallydownregulatedinadvancedcancer AT woodsmichellel rassf10isatgfbtargetthatregulatesaspp2andecadherinexpressionandactsastumorsuppressorthatisepigeneticallydownregulatedinadvancedcancer AT waleschsarak rassf10isatgfbtargetthatregulatesaspp2andecadherinexpressionandactsastumorsuppressorthatisepigeneticallydownregulatedinadvancedcancer AT gokyildirimmiray rassf10isatgfbtargetthatregulatesaspp2andecadherinexpressionandactsastumorsuppressorthatisepigeneticallydownregulatedinadvancedcancer AT kruegermarcus rassf10isatgfbtargetthatregulatesaspp2andecadherinexpressionandactsastumorsuppressorthatisepigeneticallydownregulatedinadvancedcancer AT dammannreinhardh rassf10isatgfbtargetthatregulatesaspp2andecadherinexpressionandactsastumorsuppressorthatisepigeneticallydownregulatedinadvancedcancer |